ARCHIVES

Screening Guidelines Differ Among Major Medical Organizations

This article is from The Cancer Letter archive.

Vol. 24 No. 02 | January 16, 1998

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan

June 10, 1988

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

July 26, 2013

Tell NCI About science, Not Funding Mechanisms, Broder Says to Society

January 21, 1994

Women’s Health Was ‘Highest Priority’ Of House Committee

July 31, 1992

Study Seeks Sisters Of Women With Breast Cancer

September 27, 2002

FDA Revises Package Insert, Seeks To Limit Product Liability Suits In State Courts.

January 20, 2006